{"podcast":{"title":"Charged Alpha Stock Encyclopedia","slug":"charged-alpha-stock-encyclopedia-7819792","podcast_index_feed_id":7819792,"rss_url":"https://feed.podbean.com/chargedalpha/feed.xml","website_url":"https://chargedalpha.podbean.com","image_url":"https://pbcdn1.podbean.com/imglogo/image-logo/22241603/charged_alpha_logo_2048.png","author":"Colton Thomas","episode_count":1034,"summary":"Charged Alpha reviews earnings for each stock in the Russel 1000 every quarter. Each podcast gives thorough analysis, along with an in-depth profile in the beginning of the episode of the company, what they do, how they earn money and what to look for.","last_synced_at":"2026-07-18T10:20:29.083898+00:00","page_url":"https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792"},"episode":{"title":"ISRG Stock: Intuitive Surgical BEAT Q2 2026 — So Why Did It Crash 12%? (Cheap at Last, or Value Trap?)","slug":"isrg-stock-intuitive-surgical-beat-q2-2026-so-why-did-it-crash-12-cheap-at-last-or-value-trap","published_at":"2026-07-17T17:40:44+00:00","page_url":"https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/isrg-stock-intuitive-surgical-beat-q2-2026-so-why-did-it-crash-12-cheap-at-last-or-value-trap","show_page_url":"https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792","url":"https://chargedalpha.podbean.com/e/isrg-stock-intuitive-surgical-beat-q2-2026-%e2%80%94-so-why-did-it-crash-12-cheap-at-last-or-value-trap/","audio_url":"https://mcdn.podbean.com/mf/web/gwakqwrt0p0ttab7/audio_i.mp3","summary":"Intuitive Surgical (ISRG) Q2 2026 — Intuitive Surgical (ISRG) reported a clean Q2 2026 beat: revenue $2.89B (+19% YoY), non-GAAP EPS $2.80 (beat $2.48, +28%), GAAP EPS $2.29; worldwide procedures +16% (da Vinci +15%, Ion +36%); 468 da Vinci systems placed (246 were da Vinci 5) vs 395 a year ago; installed base 11,710 (+12%). Instruments & accessories $1.73B (+18%, ~60% of revenue); non-GAAP gross margin 70.0%; operating margin >40%; $8.63B cash and zero debt; $0.38B buyback. Yet the stock FELL ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high — because FY26 da Vinci procedure-growth guidance of 13.5-15.5% marked a clear step down from the high-teens, alongside softer hospital surgery volumes and a da Vinci Class II component recall. Our owner-earnings DCF lands ~$343, essentially on top of the ~$352 price. Wall Street: Buy (39 of 56), avg target ~$525. Our call: HOLD, 3/5 — a premier compounder now at roughly fair value; not a bargain yet. Intuitive Surgical is the pioneer and monopoly of robotic-assisted surgery — the da Vinci system, the Ion lung-biopsy robot, and a razor-and-blade model where over 76% of revenue recurs. In Q2 2026 it delivered a clean beat: revenue $2.89B (+19%), non-GAAP EPS $2.80 (vs $2.48), worldwide procedures +16%, non-GAAP gross margin 70%, and 468 da Vinci placements (246 da Vinci 5), lifting the installed base 12% to 11,710. And yet the stock fell ~12.6% to a fresh 52-week low near $352 — down ~42% from its $604 high. The reason isn't the quarter; it's the guide: FY26 da Vinci procedure growth of 13.5-15.5% (management points to the midpoint) is a step down from the high-teens pace of recent years, compounded by softer hospital volumes and a Class II recall. For a stock still near 33x forward earnings, deceleratin…","meta_description":"Intuitive Surgical (ISRG) Q2 2026 — Intuitive Surgical (ISRG) reported a clean Q2 2026 beat: revenue $2.89B (+19% YoY), non-GAAP EPS $2.80 (beat $2.48, +2…","key_points":[],"chapters":[],"topics":[],"duration_seconds":870,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/charged-alpha-stock-encyclopedia-7819792/episodes/isrg-stock-intuitive-surgical-beat-q2-2026-so-why-did-it-crash-12-cheap-at-last-or-value-trap/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/charged-alpha-stock-encyclopedia-7819792/isrg-stock-intuitive-surgical-beat-q2-2026-so-why-did-it-crash-12-cheap-at-last-or-value-trap.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}